Home › Funds › BVF INC/IL › ZYME
BVF INC/IL position in ZYME
ZYMEWORKS INC · Health Care
BVF INC/IL reported holding 3,649,142 shares of ZYME (ZYMEWORKS INC) in its Q2 2026 13F filing — a position valued at US$95.4M, representing 2.44% of its reported portfolio and ranking #14 among its reported holdings. BVF INC/IL has disclosed ZYME holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How BVF INC/IL's ZYME position evolved
BVF INC/IL first disclosed a stake in ZYME in Q3 2023 at 5,870,000 shares (US$37.2M). The position peaked in Q4 2025 at 3,938,641 shares, worth US$103.7M. Across 12 filings, BVF INC/IL increased the stake 0 time(s), trimmed it 5 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 3,649,142 shares valued at US$95.4M — a reduction of -85,000 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 5.87M | $37.22M | New |
| Q4 2023 | 5.87M | $60.99M | Hold |
| Q1 2024 | 5.87M | $61.75M | Hold |
| Q2 2024 | 5.87M | $49.95M | Hold |
| Q3 2024 | 4.61M | $57.83M | Reduce |
| Q4 2024 | 4.31M | $63.08M | Reduce |
| Q1 2025 | 4.31M | $51.32M | Hold |
| Q2 2025 | 4.31M | $54.08M | Hold |
| Q3 2025 | 3.94M | $67.27M | Reduce |
| Q4 2025 | 3.94M | $103.70M | Hold |
| Q1 2026 | 3.73M | $93.50M | Reduce |
| Q2 2026 | 3.65M | $95.39M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ZYME and 13F data
ZYME (ZYMEWORKS INC) is a Health Care company. 30 other funds we track also report a position in ZYME — the largest reported positions include EcoR1 Capital, LLC (US$600.4M), Rubric Capital Management LP (US$183.0M), PERCEPTIVE ADVISORS LLC (US$109.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ZYME
- EcoR1 Capital, LLC 22.97M sh · $600.45M · Q2 2026
- Rubric Capital Management LP 7.00M sh · $182.98M · Q2 2026
- PERCEPTIVE ADVISORS LLC 4.18M sh · $109.34M · Q2 2026
- Nextech Invest Ltd. 1.11M sh · $29.12M · Q2 2026
- Prosight Management, LP 674.43K sh · $17.63M · Q2 2026
- Redmile Group, LLC 491.65K sh · $12.85M · Q2 2026
- Capricorn Fund Managers Ltd 486.53K sh · $12.72M · Q2 2026
More on BVF INC/IL
FAQ
How long has BVF INC/IL held ZYME?
BVF INC/IL has disclosed ZYME holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is BVF INC/IL's current position in ZYME?
As of Q2 2026, BVF INC/IL holds 3.65M shares of ZYME (ZYMEWORKS INC), valued at $95.39M, representing 2.44% of its reported portfolio and ranking #14.
Has BVF INC/IL been buying or selling ZYME?
In the latest 13F filing (Q2 2026), BVF INC/IL reduced its position in ZYME. The position peaked in Q4 2025 at 3.94M shares.
Which other funds hold ZYME?
Other major institutional holders of ZYME include EcoR1 Capital, LLC, Rubric Capital Management LP, PERCEPTIVE ADVISORS LLC, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.